Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-05-17
1985-04-16
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546273, 546270, 548336, 514339, 514397, A61K 3144, C07D40104, C07D40304
Patent
active
045115737
ABSTRACT:
Disclosed as thromboxane synthetase inhibitors are the compounds of formula ##STR1## wherein R.sub.1 represents hydrogen or lower alkyl;
Ar represents 3-pyridyl or 1-imidazolyl, each unsubstituted or substituted by lower alkyl, carboxy, lower alkoxycarbonyl or carbamoyl;
R.sub.2 and R.sub.3 independently represent hydrogen, lower alkyl, halogen, trifluoromethyl, hydroxy, lower alkoxy, carboxy lower alkyl, lower alkoxycarbonyl lower alkyl, carboxy, lower alkoxycarbonyl, or lower alkyl-(thio, sulfinyl or sulfonyl), or R.sub.2 and R.sub.3 together on adjacent carbon atoms represent lower alkylenedioxy;
A represents straight chain or branched alkylene of 3 to 12 carbon atoms in which the number of the carbon atoms separating the indole nucleus from group B is 3 to 12, straight chain or branched alkenylene of 2 to 12 carbon atoms, straight chain or branched alkynylene of 2 to 12 carbon atoms, lower alkylenephenylene-lower (alkylene or alkenylene), lower alkylenephenylene, lower alkylene-(thio or oxy)-lower alkylene, lower alkylene-(thio or oxy)-phenylene, or lower alkylene-phenylene-(thio or oxy)-lower alkylene;
B represents carboxy, esterified carboxy, carbamoyl, mono- or di-lower alkylcarbamoyl, hydroxymethyl, cyano, hydroxycarbamoyl, 5-tetrazolyl or formyl; the imidazolyl and pyridyl N-oxide thereof; or a pharmaceutically acceptable salt thereof; as well as their synthesis, pharmaceutical compositions thereof, and methods of treatment utilizing such compounds.
REFERENCES:
patent: 3468894 (1969-09-01), Pfenninger
patent: 3557142 (1971-01-01), Bell
patent: 4217357 (1980-08-01), Cross et al.
patent: 4226878 (1980-10-01), Itzuka et al.
patent: 4256757 (1981-03-01), Hayashi et al.
patent: 4273782 (1981-06-01), Cross et al.
patent: 4363912 (1982-02-01), Cross et al.
patent: 4410539 (1983-10-01), Cross et al.
patent: 4436746 (1984-03-01), Renfroe
patent: 4460777 (1984-07-01), Renfroe
patent: 4478842 (1984-10-01), Renfroe
Buchmann, 2-Pyrdylindoles, Pharmazie 23, 557-560 (1968) C.A. 70, 472365/(1969).
Sugasawa et al., Pharm. Bull. Japan 4, 16-19 (1956).
Buchmann et al., CA 64, 19540d (1966).
Fetizon et al., Bull. Soc. Chim., France, 1969, 4154-4159.
Takahashi et al., Chem. Abstracts, 1964, 1694d.
Fetizon et al., Bull. Soc. Chem., France, 1966, 771-772.
Kahnt et al., Acta Endocrinologica 70, 315-330 (1972).
Ciba-Geigy Corporation
Fan Jane T.
Gruenfeld Norbert
LandOfFree
3-Substituted-2-(heteroaryl) indoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-Substituted-2-(heteroaryl) indoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-Substituted-2-(heteroaryl) indoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1455744